Martin, T., Lin, Y., Agha, M., Cohen, A. D., Htut, M., Stewart, A. K., Hari, P., Berdeja, J. G., Usmani, S. Z., Yeh, T., Olyslager, Y., Goldberg, J. D., Schecter, J. M., Madduri, D., Jackson, C. C., Deraedt, W., Gries, K. S., Fastenau, J. M., Trudeau, J. J., Akram, M., Pacaud, L., Jakubowiak, A., & Jagannath, S. (2022). health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b–2, open-label study. Lancet, 9(12), e897–e905. http://access.bl.uk/ark:/81055/vdc_100170509680.0x00000b